#acute myeloid leukemia

The Latest Advancements in Immunotherapy for Adult Leukemia

James DeGregori, PhD, led research that revealed the role of the mTOR signaling pathway in AML treatment.

African Americans between 18 and 39 with acute myeloid leukemia are more likely to die within five years compared with white people.

This two-time cancer survivor and former health reporter believes “pre-habilitation” can prepare you for any health crisis.

With omicron surging in February, Suleika Jaouad’s husband Jon Batiste couldn’t be with her in the hospital.

“We were favorably surprised by the quality of tumor responses in patients."

A new study clarifies the benefits and risks of treatments for those with multiple myeloma, a blood cancer more common in Black Americans.

Ivosidenib (Tibsovo) plus chemotherapy may soon be an option for those with leukemia that has an IDH1 mutation.

Age, sex and decade of diagnoses influenced long-term survival of adolescent and young adult leukemia survivors.

Two treatment approaches using donor or engineered NK cells led to remission in people with lymphoma and leukemia.

Grammy Award winner Jon Batiste married author Suleika Jaouad a day before a bone marrow transplant to treat her acute myeloid leukemia.

The woman’s leukemia is in remission and she remains free of detectable HIV more than a year after stopping antiretroviral treatment.

Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.

Studies point to strategies to reduce disparities, improve outcomes and support shared decision-making.

A former world champion triathlete, Siri Lindley, 52, was treated for acute myeloid leukemia.

Researchers call on hematologists and pharmacists to make sure life-saving treatment is kept on-hand for patients with rare leukemia.

Soheil Meshinchi, MD, PhD, discusses developing personalized therapies for the deadliest childhood leukemia that have fewer side effects.